FDA Safety Communication Offers Recommendations for Bronchoscope Reprocessing

September 23, 2015 | Risk Management News

Preview

"Failure to meticulously follow manufacturer instructions" and "continued use of devices despite integrity, maintenance, and mechanical issues" were the two most predominant factors contributing to the contamination of reprocessed flexible bronchoscopes identified in a recent U.S. Food and Drug Administration (FDA) investigation, reports a September 17, 2015, FDA safety communication.

Access Full Content

Contact us today at 610.825.6000.